CSB-321

N/A

Report date: 2025/11/28 15:16:30

Base Information

Drug NameCSB-321

Drug Alias NameCSB-321[18F]CSB-321[Al18F]-NODA-CSB-321

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FDiagnostic agent (In vivo) > Radionuclide Imaging agent +[4]

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsSolid tumoursNeoplasm Metastasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesCytosite Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesCytosite Biopharma Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursNeoplasm Metastasis

Inactive IndicationsN/A

Other Information

ATC CodeN/A